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Abstract 
This study investigates the potential stages of drug use. Data from the longitudinal Cohort Study on 
Substance Use Risk Factors were used (N = 5,116). Drug use (alcohol, tobacco and 16 illicit drugs) over 
the past 12 months was assessed at two time points. Patterns and trajectories of drug use were studied 
using latent transition analysis (LTA). This study’s substantive contributions are twofold. First, the 
pattern of drug use displayed the well-known sequence of drug involvement (licit drugs to cannabis to 
other illicit drugs), but with an added distinction between two kinds of illicit drugs (“middle-stage” drugs: 
uppers, hallucinogens, inhaled drugs; and “final-stage” drugs: heroin, ketamine, GHB/GBL, research 
chemicals, crystal meth, and spice). Second, subgroup membership was stable over time, as the most 
likely transition was remaining in the same latent class. 
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Introduction 
The ways in which adolescents and young adults initiate and progress through types of drug use is a well-
studied topic (Hamburg, Kraemer, & Jahnke, 1975; Kandel, 1975; Kandel & Yamaguchi, 2002;  Kandel, 
Kazuo Yamaguchi, & Laura Cousino Klein, 2006; Scholey et al., 2004). This progression usually goes 
from licit drugs use (alcohol and/or tobacco), to cannabis use, and finally on to the use of other illicit 
drugs (Fergusson, Boden, & Horwood, 2006; Kandel, 2002; Kokkevi, Richardson, Florescu, Kuzman, & 
Stergar, 2007; Pape, Rossow, & Storvoll, 2009; Pentz & Li, 2002; Wagner & Anthony, 2002; Willner, 
2001; Wu, Schlenger, & Galvin, 2006). In contrast to this well-known and commonly agreed-upon 
sequence (Hamburg et al., 1975; Kandel, 1975; Kandel & Yamaguchi, 2002; Kandel et al., 2006; Scholey 
et al., 2004), the stages of involvement in illicit drugs other than cannabis remain vague. Indeed, illicit 
drugs other than cannabis are often aggregated into a single class (Kandel & Yamaguchi, 2002). As 
Kandel (2002) reported, it is difficult to establish an order of use among these drugs as they appear to be 
unstable (Hays, Stacy, Widaman, Di Matteo, & Downy, 1986; Windle, Barnes, & Welte, 1989). Heroin is 
sometimes described as the final stage of progression in drug use (Kandel, Kazuo Yamaguchi, & Cousino 
Klein, 2006; Valenzuela & Fernández, 2011; Wu et al., 2006). Cocaine, GHB/GBL and ketamine use also 
seem to be initiated at the end of this progression (Gross, Barrett, Shestowsky, & Pihl, 2002). A recent 
study identified two profiles of illicit drugs use, other than for cannabis (Baggio, Studer, Mohler-Kuo, 
Daeppen, & Gmel, 2013), separating “soft” or “middle-stage” drug users (who used uppers such as speed, 
ecstasy, cocaine; hallucinogens such as magic mushrooms or LSD; and inhaled drugs such as poppers or 
solvents) from “hard” or “final-stage” drug users (who used “soft” drugs, but also heroin, ketamine, 
GHB/GBL, research chemicals, crystal meth, and spice). However, this study had a cross-sectional design 
and thereby was unable to identify whether these profiles for drug users demonstrated any use progression 
through different illicit drugs. The current study aims to provide much more detailed information about 
the potential stages of illicit drug use (other than cannabis) in a longitudinal design. 
Beyond this well-known sequence of involvement in drug use, some studies have reported that the use of 
a drug does not necessarily lead to the use of drugs that come later in the sequence (Kandel & Davies, 
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1992). One way of studying drug progression is to model transitions using latent transition analysis 
(LTA). LTA is a longitudinal extension of latent class analysis (LCA, Goodman, 1974; Lazarsfeld & 
Henry, 1968). LCA is a multivariate model that derives classes of individuals who share common patterns 
and describes sets of characteristics parsimoniously. LTA models transitions between these class 
memberships over time, and has been used often in recent substance use research (Cleveland, Lanza, Ray, 
Turrisi, & Mallett, 2012; Kam & Collins, 2000; Ko, Martins, Kuramoto, & Chilcoat, 2010; La Flair et al., 
2013; Lanza, Patrick, & Maggs, 2010; Maldonado-Molina & Lanza, 2010; Patrick et al., 2009; Tang, 
Lanza, & Collins, 2001; White, Bray, Fleming, & Catalano, 2009). Several studies using LTA to examine 
transitions from one stage to another revealed that the most common pattern involved stopping at a 
particular stage and progressing no further along the drug use scale (Hawkins, Hill, Guo, & Battin-
Pearson, 2002; Lanza et al., 2010; Patrick et al., 2009; Tang et al., 2001). This shows that substance use 
seems to be quite stable across time; the highest probability among the transition alternatives is that 
people remain in the same latent class (Collins, 2002; Hawkins et al., 2002; Kam & Collins, 2000; Lanza 
et al., 2010; Tang et al., 2001). Tobacco use was an exception; this showed less stable patterns, for which 
participants transitioned from tobacco use only, to both tobacco and alcohol use (Kam & Collins, 2000; 
Patrick et al., 2009; Tang et al., 2001). Progression is by no means inevitable (Kandel, 2002). Substance 
use in adolescents and young adults is often experimental and recreational; very few people progress to 
using illicit drugs other than cannabis (EMCDDA, 2009). Moreover, use of some drugs is initiated after 
the teenage years (average onset of heroin use, 22.1 years of age; cocaine use, 20.1 years of age; 
SAMHSA, 2012), and studies focusing on adolescence or very early adulthood may miss the initiation of 
such substance use. How quickly transitions between the use of different substances occurs is also 
interesting. Some studies assessed such closely related measures (fall and spring semesters in college 
students, Lanza et al., 2010; 8th and 9th grades students, Patrick et al., 2009; 9th and 10th grade students, 
Hawkins et al., 2002) that they may not have been able to catch transitions from one latent class to 
another, especially in teenage years. 
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This study’s principal aim was to investigate the way in which young Swiss males in their early twenties 
changed their drug use. As the profiles of drug users described above (Baggio et al., 2013) were baseline 
data from the present study, we hypothesized that these profiles would also fit the follow-up data and that 
stages of drug use would first include alcohol use, then tobacco use, then cannabis use, followed by 
“middle-stage” illicit drugs and finally by “final-stage” illicit drugs (H1). As regards transition, following 
on from previous studies, we hypothesized that the most common transition in substance use would not 
actually be a transition, but would be to remain in the same latent class, as only a few people moved to 
illicit drug use (H2). Drug use over the past twelve months was used to test whether participants had 
stopped using drugs, and to also to investigate forward and backward transitions in substance use, the 
latter being an understudied topic. The ages of onset of alcohol, tobacco and cannabis use were also 
assessed, as these variables are known to be important ones for preventive purposes. 
 
Method 
Participants and procedures 
The present study analyzed data collected from the Cohort Study on Substance Use Risk Factors (C-
SURF). C-SURF is a longitudinal study designed to assess substance use patterns and their related 
consequences in young Swiss men. Participants were enrolled in three of Switzerland’s six army 
recruitment centers, which cover 21 of the country’s 26 cantons (including all French-speaking ones). 
These are located in Lausanne (French-speaking), Windisch and Mels (German-speaking). All young men 
of around 20 years old were eligible for study inclusion because attending army recruitment is obligatory 
in Switzerland. It is important to note that the recruitment centers were only used to enroll participants. 
Assessment of baseline and follow-up data was carried out outside the army environment, and 
independently of military service, civic service or no service at all. Baseline data were collected between 
August 23rd 2010 and November 15th 2011; follow-up data were collected between January 10th 2012 and 
April 15th 2013. 
7 
 
Participants who gave a written consent to participate in recruitment centers were invited two weeks later 
by mail or email to fill in a paper and pen or an online questionnaire, according to the favorite way they 
indicated in the written consent. The questionnaire lasted approximately 1 hour and included topics such 
as sociodemographic background, health, family background, substance use (alcohol, tobacco, cannabis, 
other illicit drugs, prescription drugs), personality and leisure time activities and sexuality. For follow-up, 
participants were again invited to fill in the questionnaire. 
A total of 5,990 participants filled in the baseline questionnaire, and 5,223 (87.2%) filled in the follow-up 
questionnaire. Missing values were listwise deleted, and the final sample consisted of 5,116 participants 
(98.0% of the follow-up sample). More information on sampling and non-response can be found in Studer 
et al. (Studer et al., 2013). Briefly, non-respondents used more alcohol, tobacco and cannabis than 
respondents, but the magnitude of the differences was small, indicating a small non-response bias. The 
study protocol (Protocol No. 15/07) was approved Lausanne University Medical School’s Ethics 
Committee for Clinical Research. 
 
Measures 
Alcohol use. Alcohol use was assessed at both baseline and follow-up by asking participants if they had 
drunk any kind of alcohol in the past 12 months: “During the last 12 months, did you have at least 1 drink 
of any kind of alcohol (not counting small tastes or sips)?” Pictures of standard drinks containing 
approximately 10-12 g of pure alcohol were provided. Answers were coded as “used” or “not used”. They 
were also asked at what age they had used alcohol for the first time. 
Tobacco use. Participants were asked at both baseline and follow-up if they had smoked during the past 
12 months: “Have you smoked cigarettes in the past 12 months?” Answers were also coded as “used” or 
“not used”. Age of first tobacco use was assessed. 
Cannabis use. Cannabis use was assessed at both baseline and follow-up by asking participants if they 
had smoked cannabis (hashish, marijuana or grass) during the past 12 months: “Have you used any 
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cannabis over the past 12 months?” Answers were coded as “used” or “not used”. Age of first cannabis 
use was also assessed. 
Illicit drug use. At both baseline and follow-up, fifteen questions measured use of illicit drugs over the 
past 12 months (“Have you taken any of the following drugs in the past 12 months?”); answers were 
coded as “used” or “not used”. The substances were as follows: 1) hallucinogens, magic mushrooms, 
psilocybin, peyote, mescaline; 2) other hallucinogens (LSD, PCP/Angel Dust, 2-CB, 2-CI); 3) salvia 
divinorum; 4) speed; 5) amphetamine, methamphetamine, amphetamine sulfate (e.g. Dexedrine, 
Benzedrine); 6) crystal meth (ice); 7) poppers (e.g. amyl nitrite, butyl nitrite); 8) solvents for sniffing (e.g. 
glues, solvents and gases such as benzine, ether, toluene, trichloroethylene, nitrous oxide); 9) ecstasy, 
MDMA; 10) cocaine, crack, freebase; 11) heroin; 12) ketamine (Special K), DXM; 13) GHB/GBL/1,4-
butanediol (BDB); 14) research chemicals (e.g. mephedrone, butylone and methedrone); and 15) spices or 
similar substances.  
 
Statistical analyses 
First, descriptive statistics were computed to estimate the prevalence rates of all drugs at baseline and 
follow-up. McNemar tests for related samples were computed for each substance at baseline and 
followed-up to assess whether there was an increase in the prevalence rates for each substance use. LTA 
was then used to derive classes of individuals who shared common patterns, and to model transitions 
between these classes over time. Two steps were used in the present study. To begin, at each time point, 
we tested alternative models for selecting the correct number of classes for the latent model (LCA at 
baseline, and LCA at follow-up). The number of latent classes was unknown, and fit indices for various 
models were used to assess the optimal number of classes. Bayesian information criterion (BIC), sample-
size adjusted BIC (ABIC) and Akaike information criterion (AIC) were used, for which lower values 
indicate a better fit (Raftery, 1995). The Lo-Mendel-Rubin likelihood ratio test (LMR LRT) indicates 
whether a model with k classes is better than a model with k-1 classes (Lo, Mendell, & Rubin, 2001). A 
low p-value indicates that the model with k-1 classes has been rejected in favor of the model with k 
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classes. Two LTA were subsequently performed to test measure invariance across time. The first model 
constrained the item-response probabilities (used to assign each participant to the most likely latent class) 
to be equal across time (measurement-invariance model), and the second model had no restrictions 
(measurement-variance model). The likelihood-ratio statistic was given for each model. A Chi-square 
statistic between the measurement-invariance model and measurement-variance model was computed to 
determine whether the structure of substance use behavior differed across time. This was an important 
step from a conceptual point of view, i.e. the meaning of latent classes remains the same over time. It was 
also important from a statistical point of view, i.e. the fewer the parameters, the more stable the 
estimation (Lanza et al., 2001). Class membership and transition probabilities were discussed for the 
model that best fitted the data. Three kinds of information are provided: 1) probabilities of substance use 
in each class; 2) the percentage of users in each latent class; and 3) transition probabilities (e.g. changes of 
latent class membership between baseline and follow-up). These analyses were performed using SPSS 21 
for descriptive statistics and the comparisons of proportions, and using Mplus 6 (Muthén & Muthén, 
2010) for LTA.  
 
Results 
Preliminary results 
The mean age of the participants was 19.97 ± 1.21 years at baseline and 21.26 ± 1.23 years at follow-up. 
Around 15 months separated baseline data collection from follow-up data collection. Respondents and 
non-respondents at follow-up did not differ by age (non-respondents at baseline: 20.24 ± 1.39). For 5 out 
of 18 substances (tobacco, cannabis, ecstasy, cocaine and heroin) non-respondents were more often 
substance users than respondents. Ages at first alcohol, tobacco and cannabis use were 14.42 ± 2.14 years, 
14.70 ± 2.50 and 15.87 ± 1.90, respectively. Table 1 presents percentages of use for each drug at the two 
time points. Alcohol was the most commonly used substance (92.7% of the sample at both baseline and 
follow-up). Tobacco and cannabis were respectively the second and third most used substances (45.6% 
and 46.6% used tobacco, and 30.0% and 31.0% used cannabis, at baseline and follow-up, respectively). 
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Thus the use of these substances remained stable over time (alcohol: p = .951; tobacco: p = .067; 
cannabis: p = .072). With regards to other illicit drugs, these can be categorized into two groups. 
Hallucinogens (magic mushrooms, others hallucinogens, salvia divinorum), uppers (ecstasy, cocaine, 
speed, amphetamine/methamphetamine) and inhalants (poppers, solvents) showed higher prevalence rates 
than spice, ketamine, GHB/GBL, crystal meth, research chemicals and heroin, at both baseline and 
follow-up. For the first group (labeled “middle-stage drugs”), prevalence rates ranged between 1.8% and 
3.4% at baseline and 2.1% and 5.2 % at follow-up. For the second group (labeled “final-stage drugs”), 
prevalence rates ranged between 0.3% and 0.5% at baseline and 0.7% and 0.9% at follow-up. Use of 9 out 
of 15 illicit drugs increased between the baseline and the follow-up. The most pronounced increases in 
illicit drugs were ecstasy (3.4% at baseline, 5.2% at follow-up, p < .001), cocaine (2.8% at baseline, 3.9% 
at follow-up, p < .001) and heroin (0.5% at baseline, 0.8% at follow-up, p < .001). 
 
Insert Table 1 about here 
 
Assessing the optimal number of latent classes 
Six models were used on both the baseline and follow-up surveys, using latent class analysis to estimate 
the optimal number of classes. The fit indices are presented in Table 2. The five-class model was the best 
one for both the baseline and follow-up data because it demonstrated the best fit indices. Even if AIC 
decreased for the six-class model, the LMR LRT showed non-significant p-values for this model, and the 
BIC and ABIC increased. The next step was performed using a five-class model for both time points. 
 
Insert Table 2 about here 
Latent transition analysis: assessing measurement invariance 
The Chi-square statistic was used to test the structure of measurement and to assess which between 
measurement-invariance model and measurement-variance model over time was the best model. The 
results showed χ2 (90) = 47.07, p = .99. This non-significant p-value indicated that the structure of 
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substance use behavior did not change over time, i.e. the latent classes (for both baseline and follow-up) 
showed the same pattern. The measurement-invariance model was validated for use. 
 
Latent transition analysis: examining patterns of drug use over time 
In the first panel of Table 3, the item-response probabilities were thus constrained to be equal at baseline 
and follow-up for each of the five classes of substance use behavior. The first latent class was labeled 
‘alcohol users only’, because participants in this class had a high probability of alcohol use (.875) and 
low probabilities of other substance use (probability .045 and lower). The second latent class was labeled 
‘alcohol and tobacco users’ as participants in this class showed high probabilities of alcohol (.969) and 
tobacco (.929) use, but low probabilities for other substance use (probability .179 for cannabis use, and 
.018 and lower for all other illicit drugs). The third latent class was labeled ‘alcohol, tobacco and 
cannabis users’ because participants had high probabilities of using these three substances (.989, .819 
and .955, respectively), but not the other illicit drugs (probability .048 and lower). The fourth latent class 
was labeled ‘alcohol, tobacco, cannabis and “middle-stage” drugs users’, who used many drugs 
(alcohol: .973; tobacco: .941; cannabis: .909; “middle-stage” drugs: from .119 to .697), but not “final-
stage” drugs, for which probabilities were lower (probability .055 and lower). The fifth and final latent 
class referred to ‘all drug users’, including both “middle-stage” and “final-stage” drugs (probabilities 
from .641 to .961) in addition to alcohol (.846), tobacco (.447) and cannabis (.449). Participants who were 
non-alcohol users (7.3% of the sample) mostly belonged to the second latent class (84.9% of them). 
Users of alcohol only (class 1) were the most prevalent class (49.33% at baseline, 47.89% at follow-up), 
and all drugs users (class 5) were the least prevalent class (0.31% at baseline, 0.70% at follow-up). 
McNemar tests for paired samples were also performed for each latent class, comparing proportions of 
users at baseline and follow-up. Consistent with the first part of the analysis, differences in prevalence 
rates only increased significantly for the last two classes, including “middle-stage” drug users and “final-
stage” drug users. The percentage of users in the three first classes (alcohol, tobacco and cannabis users) 
was stable over time (second class) or decreased significantly (first and third classes). Transition 
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probabilities contained in the third panel of Table 3 showed that the most common transition was not a 
transition at all, but rather to remain in the same latent class at baseline and follow-up. Indeed, the 
diagonal of the matrix (in bold font) shows this. Users of alcohol only (class1) at baseline had a 
probability of .896 of still being classified in this class at follow-up. The other classes also showed high 
probabilities for their membership to be stable over time (alcohol and tobacco users: .842; alcohol, 
tobacco and cannabis users: .898; alcohol, tobacco, cannabis and “middle-stage” drug users: .840), except 
for the class of all drug users. This was the least stable class, showing the highest probability of not 
remaining in the same class (.419). The second highest transition probability, with .183, was a move from 
the all drug user class to the alcohol only user class. The transitions from alcohol to alcohol and tobacco 
use, and from alcohol, tobacco and cannabis use to alcohol, tobacco, cannabis and “middle-stage” drugs 
use, were the most interesting ones. Participants had a probability of .080 of progressing from alcohol to 
alcohol and tobacco use (the second highest probability for alcohol users at baseline). On the other hand, 
participants had a probability of .120 of transitioning from alcohol and tobacco use to alcohol use only 
(the second highest probability for alcohol and tobacco users at baseline). The same pattern of transitions 
was shown for alcohol, tobacco and cannabis users, and for alcohol, tobacco, cannabis and “middle-stage” 
drugs users: the probability of progressing from the first to the second latent class was .058 (the second 
highest probability for alcohol, tobacco and cannabis users at baseline), whereas the probability of 
transitioning from alcohol, tobacco, cannabis and “middle-stage” drugs use to alcohol, tobacco and 
cannabis use was .061 (the second highest probability for alcohol, tobacco, cannabis and “middle-stage” 
drug users at baseline).  
The ages of first use of alcohol, tobacco and cannabis were earlier for the last class, users of all drugs 
(10.69, 10.64 and 10.55 years old, respectively). Users who were part of the fourth class also showed 
early use of alcohol, tobacco and cannabis (12.98, 13.35 and 14.56 years old, respectively), whereas users 
of the first class (alcohol users only) showed later first use (14.90, 14.93 and 16.38 years old, 
respectively). 
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Discussion 
Main findings 
This study aimed to investigate the ways in which young adults, part of a sample of Swiss males, progress 
between the uses of different drugs. Transitions to both more and less drug use were investigated. 
First, the results showed that participants exhibited high prevalence rates of alcohol, tobacco and cannabis 
use, which remain stable over time. Indeed, these three substances are often the first to be experienced 
during teenage years, and one can suppose that many of the 20 to 21-year-old participants had already 
experienced these substances. Nine out of 18 substances showed an increase in use between the baseline 
and follow-up. The substances that showed the highest increase in use were ecstasy, cocaine and heroin. 
This result is in accordance with the conclusions of previous studies (e.g. SAMHSA, 2012) which showed 
that the mean ages for first use of cocaine and heroin were 20.1 and 22.1 years old, respectively. 
Unfortunately, these studies (EMCDDA, 2009; SAMHSA, 2012) have no data for ecstasy and other illicit 
drugs, but the fact that most of the illicit drugs in our study showed an increase in use seemed to be in 
accordance with the idea that participants had reached an age at which they started to experiment with 
illicit drugs other than cannabis. 
The results of LTA confirmed the validity of splitting illicit drugs other than cannabis into two separate 
classes (H1). A five-class model proved to have the best fit. The classes reflected the stages of 
involvement in drug use. The first class referred to users of alcohol only; the second class to users of 
alcohol and tobacco; the third class to users of alcohol, tobacco and cannabis; the fourth class to users of 
alcohol, tobacco, cannabis and “middle-stage” drugs; and the fifth class to all drug users (alcohol, 
tobacco, cannabis, “middle-stage” and “final-stage” drugs). Each class added substances to those used by 
the previous class. These results have been described already elsewhere (Baggio et al., 2013), but the 
present study also showed that there were two reasons why this pattern was quite stable. First, the latent 
classes were the same at baseline and follow-up (i.e. the same groups of users were found at both time 
points), and second, the structure of substance use behavior remained the same over time, with 
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measurement invariance across time (e.g. the classes were constituted in the same way, with same 
probabilities of each substance use at both time points). 
An additional result was that there was no class of “non-users”. This result contrasted with previous 
studies using LTA, which have usually shown a class of non-users (Kam & Collins, 2000; Lanza et al., 
2010; Patrick et al., 2009; Tang et al., 2001). However, the participants in the current study were older 
than those mentioned above which focused on teenagers, and this enhanced the fact that this study dealt 
with involvement further along the drug course. 
Furthermore, LTA did not show a progression within classes of substance use. The most common 
transition was not a transition at all, but rather participants remained in the same latent class: that is to 
say, they kept using the same drugs without adding new ones and transitioning to the next stage. This was 
despite the fact that the proportions of users of classes including “middle-stage” drugs and “final-stage” 
drugs increased between baseline and follow-up. This result was in accordance with hypothesis H2 and 
with previous studies which concluded that the most common pattern was to stop at a particular stage and 
not to progress further (Collins, 2002; Hawkins et al., 2002; Kam & Collins, 2000; Lanza et al., 2010; 
Patrick et al., 2009; Tang et al., 2001). However, even if the transitions mostly remained stable, one can 
see some interesting transitions between alcohol and alcohol/tobacco use, and alcohol/tobacco/cannabis 
and alcohol/tobacco/cannabis/” middle-stage” drug use. A non-negligible amount of participants progress 
from one class to the next (7.5% of alcohol users transitioned to alcohol/tobacco use, and 5.7% of 
alcohol/tobacco/cannabis users transitioned to alcohol/tobacco/cannabis/“middle-stage” drugs use). On 
the other hand, some participants also regressed from one class to the previous one (11.0% of 
alcohol/tobacco users transitioned back to alcohol use alone, and 6.4% of 
alcohol/tobacco/cannabis/“middle-stage” drugs users transitioned to alcohol/tobacco/cannabis use). Thus 
there were clearly two patterns of transitions that could occur when participants did not remain in the 
same latent class. Whereas some users progressed along the drug use course, others stopped using drugs 
and went back down to a previous latent class. This regression may be synonymous of experimental drug 
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use. Participants tried a drug, but after their experience they did not remain users and moved back down a 
stage in the drug use course.  
To summarize, drug prevalence rates significantly increased for half of all the substances investigated, but 
this progression only concerned illicit drugs other than cannabis. Most users actually stayed within their 
latent class. One explanation may be that even though the use of some substances had increased, overall 
prevalence rates remained low, and only a small number of participants were users of “middle-stage” or 
“final-stage” drugs. As mentioned in the introduction, only a few people actually transitioned to illicit 
drug use (between 0.3% and 5.2% used illicit drugs other than cannabis in descriptive statistics, and the 
percentages of latent classes including “soft” and “hard” drugs were respectively 0.28% and 5.33%) 
(Kandel, 2002; EMCDDA, 2009), and the transition probabilities showed that the most common 
trajectories were not actually progressions in drug involvement.  
Ages of first use of alcohol, tobacco and cannabis according to the different classes of drug users showed 
that the more participants used drugs, the younger they had probably been when they first experienced 
alcohol, tobacco and cannabis. This result was especially true for the last latent class of all drugs users, 
including “final-stage” drugs. On average, participants in this class had had their first experiences with 
alcohol, tobacco and cannabis in their teenage years. This result especially underlined the importance of 
early preventive actions—actions, which should no doubt continue with young adults, because drug users 
in their early twenties were more likely to remain in the same latent class and continue in their current 
drug use pattern, rather than reduce use. 
 
Limitations 
This study had several limitations. First, this study also focused on drug use over the past 12 months, 
without taking into account whether it was light or heavy use. This variable is undoubtedly a crucial one 
in any potential progression along the drug course, and should be considered in further studies. A second 
shortcoming is that no women could be included. Further investigations are needed to see whether the 
patterns and progression of drug use also fit women’s substance use behavior. Finally, a last limitation 
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was that participants were a sample of males in their early twenties, with average age lower than average 
age of onset of heroin use (i.e. 22.1 years). Indeed, prevalence rates may be lower for “final-stage” drugs 
experienced later, resulting in separate latent classes. More studies with participants in their middle 
twenties and late twenties are needed to encapsulate transitions to “final-stage” drugs. 
 
Conclusion 
To conclude, the substantive contributions of this study are threefold. First, the pattern of drug use 
followed the well-known sequence of drug involvement (from licit drugs to cannabis, and then on to other 
illicit drugs), but a distinction was added between two kinds of other illicit drugs (“middle-stage” drugs: 
uppers, hallucinogens, and inhaled drugs; and “final-stage” drugs: heroin, ketamine, GHB/GBL, research 
chemicals, crystal meth, and spice). Second, there was no latent class of non-users. Participants belonged 
to at least the alcohol users’ class. Third, latent class membership was stable over time as the most likely 
transition between baseline and follow-up was not a transition at all, but rather to remain in the same 
latent class. Progression along the drug course up to illicit drugs other than cannabis remains rare among 
participants in their twenties, since very few people move on to the use of the hardest drugs. Indeed, 
preventive action should focus on teenagers, including teenagers in their early teens, as young users were 
more likely to progress to illicit drug use.  
 
References 
Baggio, S., Studer, J., Mohler-Kuo, M., Daeppen, J.-B., & Gmel, G. (2013). Profiles of drug users in 
Switzerland and effects of early-onset intensive use of alcohol, tobacco and cannabis on other 
illicit drug use. Swiss Medical Weekly, 143.  
Cleveland, M. J., Lanza, S. T., Ray, A. E., Turrisi, R., & Mallett, K. A. (2012). Transitions in first-year 
college student drinking behaviors: Does pre-college drinking moderate the effects of parent- and 
peer-based intervention components? Psychology of Addictive Behaviors, 26, 440-450.  
17 
 
Collins, L. M. (2002). Using latent transition analysis to examine the Gateway Hypothesis. In D.B. 
Kandel (Ed.), Stages and pathways of drug involvement (pp. 254-269). Cambridge: Cambridge 
University Press,. 
EMCDDA. (2009). Polydrug use: Patterns and responses. Lisbon: European Monitoring Centre for 
Drugs and Drug Addiction. 
Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2006). Cannabis use and other illicit drug use: testing 
the cannabis gateway hypothesis. Addiction, 101, 556-569.  
Goodman, L. A. (1974). Exploratory latent structure analysis using both identifiable and unidentifiable 
models. Biometrika, 61, 215-231.  
Gross, S. R., Barrett, S. P., Shestowsky, J. S., & Pihl, R. O. (2002). Ecstasy and drug consumption 
patterns: a Canadian rave population study. Canadian Journal of Psychiatry, 47, 546-551.  
Hamburg, B. A., Kraemer, H. C., & Jahnke, W. (1975). A hierarchy of drug use in adolescence: 
Behavioral and attitudinal correlates of substantial drug use. The American Journal of Psychiatry, 
132, 1155-1163.  
Hawkins, J. D., Hill, K. G., Guo, J., & Battin-Pearson, S. R. (2002). Substance use norms and transitions 
in substance use: Implications for the Gateway Hypothesis. In D.B. Kandel (Ed.), Stages and 
Pathways of Drug Involvement (pp. 42-64). Cambridge: Cambridge University Press. 
Hays, R. D., Stacy, A. W., Widaman, K. F., Di Matteo, M. R., & Downy, R. (1986). Multistage path 
models of adolescent alcohol and drug use: A reanalysis. The Journal of Drug Issues, 16, 357-
369.  
Kam, C. M., & Collins, L. M. (2000). Latent transition analysis of substance use among adolescents in 
the National Longitudinal Survey of Youth. University Park, PA: The Methodology Center, The 
Pennsylvania State University. 
Kandel, D. B. (1975). Stages in adolescent involvement in drug use. Science, 190, 912-914.  
18 
 
Kandel, D. B. (2002). Examining the gateway hypothesis stages and pathways of drug involvement. In 
D.B. Kandel (Ed.), Stages and pathways of drug involvement: Examining the gateway hypothesis 
(pp. 3-15). Cambridge: Cambridge University Press. 
Kandel, D. B., & Davies, M. (1992). Progression to regular marijuana involvement: Phenomenology and 
risk factors for near-daily use. In M. D. Glantz & R. W. Pickens (Eds.), Vulnerability to drug 
abuse (pp. 211-253). Washington, DC, US: American Psychological Association. 
Kandel, D. B., & Yamaguchi, K. (2002). Stages of involvement in the U.S. population. In D.B. Kandel 
(Ed.), Stages and pathways of drug involvement: Examining the gateway hypothesis (pp. 65-89). 
Cambridge: Cambridge University Press. 
Kandel, D. B., Yamaguchi, K., & Klein, L. C. (2006). Testing the Gateway Hypothesis. Addiction, 101, 
470-472; discussion 474-476.  
Ko, J. Y., Martins, S. S., Kuramoto, S. J., & Chilcoat, H. D. (2010). Patterns of alcohol-dependence 
symptoms using a latent empirical approach: associations with treatment usage and other 
correlates. Journal of Studies on Alcohol and Drugs, 71, 870-878.  
Kokkevi, A., Richardson, C., Florescu, S., Kuzman, M., & Stergar, E. (2007). Psychosocial correlates of 
substance use in adolescence: A cross-national study in six European countries. Drug and Alcohol 
Dependence, 86, 67-74.  
La Flair, L. N., Reboussin, B. A., Storr, C. L., Letourneau, E., Green, K. M., Mojtabai, R., . . . Crum, R. 
M. (2013). Childhood abuse and neglect and transitions in stages of alcohol involvement among 
women: A latent transition analysis approach. Drug and Alcohol Dependence. In press. 
Lanza, S. T., Patrick, M. E., & Maggs, J. L. (2010). Latent transition analysis: Benefits of a latent variable 
approach to modeling transitions in substance use. Journal of Drug Issues, 40, 93-120.  
Lazarsfeld, P. F., & Henry, N. W. (1968). Latent structure analysis. Boston, MA: Houghton Mifflin. 
Lo, Y., Mendell, N. R., & Rubin, D. B. (2001). Testing the number of components in a normal mixture. 
Biometrika, 88, 767-778.  
19 
 
Mackesy-Amiti, M. E., Fendrich, M., & Goldstein, P. J. (1997). Sequence of drug use among serious drug 
users: typical vs atypical progression. Drug and Alcohol Dependence, 45, 185-196.  
Maldonado-Molina, M. M., & Lanza, S. T. (2010). A framework to examine gateway relations in drug 
use: An application of latent transition analysis. Journal of Drug Issues, 40, 901-924.  
Muthén, L. K., & Muthén, B. O. (2010). Mplus user's guide. Sixth edition. Los Angeles, CA: Muthén & 
Muthén. 
Pape, H., Rossow, I., & Storvoll, E. E. (2009). Under double influence: Assessment of simultaneous 
alcohol and cannabis use in general youth populations. Drug and Alcohol Dependence, 101, 69-
73.  
Patrick, M. E., Collins, L. M., Smith, E., Caldwell, L., Flisher, A., & Wegner, L. (2009). A prospective 
longitudinal model of substance use onset among South African adolescents. Substance Use & 
Misuse, 44, 647-662.  
Pentz, M. A., & Li, C. (2002). The gateway theory applied to prevention. In D.B. Kandel (Ed.), Stages 
and Pathways of Drug Involvement: Examining the Gateway Hypothesis (pp. 139-157). 
Cambridge: Cambridge University Press. 
Raftery, A. E. (1995). Bayesian model selection in social research. Sociological Methodology, 25, 111-
163.  
SAMHSA. (2012). Results from the 2011 national survey on drug use and health: Summary of national 
findings. Rockville, MD: Substance Abuse and Mental Health Services Administration. 
Scholey, A. B., Parrott, A. B., Buchanan, T., Heffernan, T. M., Ling, J., & Rodgers, J. (2004). Increased 
intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA 
users: a WWW study. Addictive Behaviors, 29, 743-752.  
Studer, J., Baggio, S., Mohler-Kuo, M., Dermota, P., Gaume, J., Bertholet, N., . . . Gmel, G. (2013). 
Examining non-response bias in substance use research—Are late respondents proxies for non-
respondents? Drug and Alcohol Dependence. In press. 
20 
 
Tang, Z., Lanza, S. T., & Collins, L. M. (2001). Modeling adolescent substance use using latent 
transition analysis: The healthy for life data set. University Park, PA: The Methodology Center, 
The Pennsylvania State University. 
Valenzuela, E., & Fernández, M. (2011). The sequence of drug use: Testing the Gateway Hypothesis in 
Latin America. The Journal of International Drug, Alcohol and Tobacco Research, 1, 1-8.  
Wagner, F. A., & Anthony, J. C. (2002). Into the world of illegal drug use: Exposure opportunity and 
other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine. American Journal 
of Epidemiology, 155, 918-925.  
White, H. R., Bray, B. C., Fleming, C. B., & Catalano, R. F. (2009). Transitions into and out of light and 
intermittent smoking during emerging adulthood. Nicotine & Tobacco Research, 11, 211-219.  
Willner, P. (2001). A view through the gateway: expectancies as a possible pathway from alcohol to 
cannabis. Addiction, 96, 691-703.  
Windle, M., Barnes, G. M., & Welte, J. (1989). Causal models of adolescent substance use: An 
examination of gender differences using distribution-free estimators. Journal of Personality and 
Social Psychology, 56, 132-142.  
Wu, L.-T., Schlenger, W. E., & Galvin, D. M. (2006). Concurrent use of methamphetamine, MDMA, 
LSD, ketamine, GHB, and flunitrazepam among American youths. Drug and Alcohol 
Dependence, 84, 102-113.  
  
21 
 
Table 1. Percentages of drug use and comparisons across time with McNemar test for related samples  
(N = 5,116) 
 Baseline Follow-up McNemar p-value 
Alcohol  92.7 92.7 .951 
Tobacco 45.6 46.6 .067 
Cannabis 30.0 31.0 .072 
Hallucinogens/magic mushrooms 2.7 3.4 .007 
Ecstasy 3.4 5.2 < .001 
Cocaine 2.8 3.9 < .001 
Salvia divinorum 2.1 2.0 .933 
Poppers 2.5 2.7 .505 
Solvents for sniffing 2.2 2.1 .596 
Speed 2.4 3.1 .011 
Other hallucinogens 2.1 2.6 .062 
Amphetamine/methamphetamine 1.8 2.5 .001 
Spice 0.5 0.7 .112 
Ketamine 0.5 0.9 .008 
GHB/GBL 0.5 0.8 .054 
Crystal meth 0.4 0.7 .025 
Research chemicals 0.4 0.8 .002 
Heroin 0.3 0.8 < .001 
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Table 2. Comparisons of different LCA models for baseline and follow-up data 
  Model BIC ABIC AIC LMR p-value 
Baseline 
One-class 27683 27625 27565 - 
Two-class 23928 23811 23687 .000 
Three-class 22773 22595 22408 .000 
Four-class 22625 22386 22135 .014 
Five-class 22363 22363 22048 .002 
Six-class 22779 22420 22041 .349 
Follow-up 
One-class 30811 30754 30694 - 
Two-class 25556 25439 25315 .000 
Three-class 24353 24175 23988 .000 
Four-class 23754 23485 23234 .000 
Five-class 23720 23421 23106 .007 
Six-class 23799 23440 23062 .205 
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Table 3. Five-class model of substance use 
  Latent classes2 
    Class 1 Class 2 Class 3 Class 4 Class 5 
Probability of substance use1      
 Alcohol  .875 .969 .989 .973 .846 
 Tobacco .015 .929 .819 .941 .447 
 Cannabis .045 .179 .955 .909 .449 
 Hallucinogens/magic mushrooms .002 .001 .048 .330 .882 
 Ecstasy .002 .003 .018 .697 .961 
 Cocaine .001 .004 .021 .514 .860 
 Salvia divinorum .000 .002 .029 .204 .869 
 Poppers .006 .018 .034 .171 .748 
 Solvents for sniffing .006 .014 .028 .119 .709 
 Speed .000 .004 .008 .434 .947 
 Other hallucinogens .000 .001 .007 .371 .902 
 Amphetamine/methamphetamine .001 .002 .005 .333 .938 
 Spice .000 .000 .006 .034 .641 
 Ketamine .000 .000 .001 .055 .847 
 GHB/GBL .000 .000 .001 .042 .793 
 Crystal meth .000 .000 .000 .033 .714 
 Research chemicals .000 .000 .001 .039 .734 
  Heroin .000 .000 .000 .030 .846 
Percentages of latent class membership      
 Baseline 49.33%a 26.00%a 20.35%a 4.01%a 0.31%a 
  Follow-up 47.89%b 26.42% a 19.72%b 5.28% b 0.70%b 
Transition probabilities3    
 Class 1 .8964 .080 .014 .005 .006 
 Class 2 .120 .842 .019 .017 .002 
 Class 3 .022 .015 .898 .058 .007 
 Class 4 .012 .065 .061 .840 .022 
  Class 5 .183 .085 .155 .158 .419 
Ages of first use (for baseline classes)    
 Alcohol 14.90 14.23 13.88 12.98 10.69 
 Tobacco 14.93 14.97 14.54 13.35 10.64 
 Cannabis 16.38 16.07 15.82 14.56 10.55 
1 Item-response probabilities constrained to be equal at baseline and follow-up. 
2 Class 1: alcohol users only; class 2: alcohol and tobacco users; class 3: alcohol, tobacco and cannabis users; class 4: alcohol, 
tobacco, cannabis and “middle-stage” drug users; class 5: all drug users, including “final-stage” drugs. 
3 Baseline: rows, follow-up: columns. 
4 Transition probabilities in bold font correspond to membership of the same latent class at each time point. 
a, b McNemar test for each latent class was performed, comparing baseline and follow-up proportions. A same subscript letter 
denotes that proportions did not differ at baseline and follow-up, two different subscript letters denote that proportions differ at 
the .001 level (.002 for class 5). 
 
